Catalyst

Slingshot members are tracking this event:

GlaxoSmithKline (GSK) and Innovia (INVA) Report Top-line from a Non-Inferiority Study of Asthma Patients Switching from Seretide Accuhaler to Relvar Ellipta

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
INVA

100%
GSK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Top-line, Non-inferiority Study, Asthma Patients, Seretide Accuhaler, Relvar, Ellipta